Medico Remedies Limited (NSE:MEDICO)
34.84
-1.50 (-4.13%)
Sep 18, 2026, 3:29 PM IST
Medico Remedies Revenue
Medico Remedies had revenue of 694.01M INR in the quarter ending June 30, 2026, with 81.43% growth. This brings the company's revenue in the last twelve months to 2.38B, up 49.96% year-over-year. In the fiscal year ending March 31, 2026, Medico Remedies had annual revenue of 2.06B with 36.73% growth.
Revenue (ttm)
2.38B
Revenue Growth
+49.96%
P/S Ratio
1.22
Revenue / Employee
22.62M
Employees
105
Market Cap
2.91B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.06B | 554.37M | 36.73% |
| Mar 31, 2025 | 1.51B | 60.20M | 4.15% |
| Mar 31, 2024 | 1.45B | 44.83M | 3.19% |
| Mar 31, 2023 | 1.40B | 194.16M | 16.04% |
| Mar 31, 2022 | 1.21B | -13.69M | -1.12% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sigachi Industries | 4.71B |
| Valiant Laboratories | 3.06B |
| Amanta Healthcare | 2.91B |
| Balaxi Pharmaceuticals | 2.80B |
| Anlon Healthcare | 2.26B |
| Bafna Pharmaceuticals | 1.43B |
| Alpa Laboratories | 1.11B |
| Par Drugs and Chemicals | 1.09B |
Medico Remedies News
- 11 months ago - Medico Remedies shares surge nearly 5% after winning $1.78 million order from Turkmenistan government - Business Upturn